AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
INSMED Inc's Nicole Schaeffer Orlov S buys 30k shares, sells others at varying prices.
ByAinvest
Friday, Nov 14, 2025 4:27 pm ET1min read
Insmed Inc. (INSM) has recently announced that Nicole Schaeffer Orlov S, the company's Chief People Strategy Officer, made significant transactions involving the purchase and sale of shares on November 12, 2025. Specifically, she acquired 30,000 shares at $26.46 per share, while simultaneously selling 4,078, 6,575, 19,183, and 164 shares at respective prices of $192.45, $193.64, $194.44, and $195.88 per share. These transactions occurred on the same date, and the details of the sales transactions suggest a significant net disposition of shares by the Chief People Strategy Officer.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet